A new simple, precise, accurate and selective TLC-densitometry method has been developed for simultaneous determination of bisoprolol fumarate and hydrochlorothiazide in tablet dosage form. Chromatographic separation was performed on aluminum plate precoated with silica gel 60F254, using chloroform: ethanol: glacial acetic acid fumarate and hydrochlorothiazide were 0.62 and 0.40, respectively. The reliability of the method was assessed by evaluation of linearity which was found to be 200-1200 ng/spot for bisoprolol fumarate and 100-800 ng/spot for hydrochlorothiazide. Accuracy of the method was accessed by % recovery and found to be 100.02 ± 1.14% for bisoprolol fumarate and 99.91 ± 0.96% for hydrochlorothiazide. The method can be used for routine analysis of bisoprolol fumarate and hydrochlorothiazide in tablet dosage form.
Introduction
Bisoprolol fumarate (BF), (+/-) -1-(4-((2-(-methyl ethoxy) ethoxy) methyl) phenoxy)-3-((1-methylethyl) amino)-2-propanol (e)-2butendioate is a competitive beta (1) -selective adrenergic antagonist [1] . Hydrochlorothiazide (HCTZ), is 6-chloro-3, 4-dihydro-7-sulfamoyl-2H-1, 2, 4-benzothiadizine 1, 1-dioxide (5) [e] is a benzothiadiazine diuretc [2] . The chemical structures are as shown in figure 1 .
Literature survey reveals, many analytical methods such as HPLC [3, 4] , TLC-densitometry [5] , fluorimetric determination [6] , LC-MS [7] , enantioanalysis human plasma [8] for estimation of BF in pharmaceutical formulation and biological fluids. Various analytical methods such as HPLC [9-12], differential pulse voltameter [13] , stability indicating determination [14] , photometric determination of HCTZ [15] were reported. BF is official in USP [16] , whereas HCTZ is official in USP, IP [17] and BP [18] .
The purpose of this work is to establish and validate a simple accurate and reproducible procedure for quantitative TLC analysis of bisoprolol fumarate and hydrochlorothiazide in tablet dosage form as per ICH guidelines [19, 20] .
Experimental

Chemicals and reagents
Bisoprolol fumarate was supplied by Rusan Pharma Ltd., India and HCTZ was supplied by IPCA Lab, India as a gift sample. Qualiz 5 tablets containing 5 mg of bisoprolol fumarate and 6.25 mg of hydrochlorothiazide were obtained from commercial sources within their shelf life period. All the reagents used were of HPLC grade.
HPTLC instrumentation
The samples were spotted in the form of bands of width 6 mm with a camag 100 µl sample (Hamilton, Bonaduz., Switzerland) syringe on precoated silica gel aluminium plate 60 F 254 (20 cm×10 cm with 0.2 mm thickness), supplied by Anchrom technologists, (Mumbai) using a camag Linomat 5 applicator (Switzerland). A constant application rate of 150 nl sec -1 was employed and space between two bands was 15 a b mm. The slit dimension was kept 6 mm×0.45 mm micro. The mobile phase consisted of chloroform: ethanol: glacial acetic acid 5: 1.5: 0.2 (v/v). The optimized chamber saturation time for mobile phase was 15 min at room temp (25°C ± 2) and relative humidity 60% ± 5. The length of chromatogram run was approximately 80 mm. Subsequent to the development; TLC plates were dried in current of air with the help of an air dryer. Densitometric scanning was performed using Camag TLC scanner 3 in the absorbance mode at 225 nm. The source of radiation utilized was deuterium lamp emitting a continuous UV spectrum in the range of 190-400 nm.
Preparation of standard solution and linearity study
An accurately weighed quantity 10 mg each of BF and HCTZ were transferred to two different 10 ml volumetric flasks, dissolved in methanol and volume was made up to mark with the same solvent to obtain concentration 1000 ng/μl each.
Aliquots of standard solution 0.2, 0.4, 0.6, 0.8, 1.0 and 1.2 µl of BF and 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7 and 0.8 µl of HCTZ were applied on TLC plate with the help of microlitre syringe, using Linomat 5 sample applicator.
Method validation
Accurately weighed 10 mg of BF and 12.5 mg of HCTZ were transferred to 25 ml volumetric flask, dissolved in methanol and volume was adjusted to mark. This mix standard solution was used for validation study.
Precision: Repeatability of measurement of peak area was determined by spotting 400 ng/spot of BF and 500 ng/spot of HCTZ. Precision of the method was assessed by intra-day and inter-day variations. Intra-day variations were assessed by spotting 200, 400, 600 ng/spot of BF and 250, 500, 750 ng/spot of HCTZ on TLC plate on three different times within the same day. Inter-day variations were performed by analysing same concentrations described above for BF and HCTZ in three different days over a period of week.
Specificity: Specificity of the method was ascertained by analysing standard drug and sample. The mobile phase resolved both the drugs very efficiently, as shown in figure 2 . The spot for BF and HCTZ was confirmed by comparing the R f and spectra of the spot with that of standard. A typical absorption overlain spectrum of BF and HCTZ shown in figure 3; wavelength 225 nm was selected for densitometric scanning. Peak purity of BF and HCTZ was assessed by comparing the spectra of sample with that of standard at three different levels, i.e., peak start (S), peak apex (M) and peak end (E) positions.
Accuracy:
The pre-analysed samples were overspotted with extra 80, 100 and 120% of the standard drug solution of BF and HCTZ on TLC plate. The total concentrations of the drugs were determined. The experiment was conducted in triplicate. This was done to check for the recovery of the drug at different levels in formulation.
Robustness: Robustness of the method was performed by spotting 400 ng of BF and 500 ng of HCTZ on TLC plate by making small deliberate changes in chromatographic conditions. Mobile phases having different composition like chloroform: ethanol: glacial acetic acid (5:1.5:0.2 v/v) and chloroform: ethanol: glacial acetic acid (4.5: 2: 0.2 v/v) were tried and chromatograms were run. The development distance was varied from 7, 7.5 and 8 cm. The amount of mobile phase (6.7 and 13.4) was tried and chromatograms were run. Temperature and relative humidity was varied in the range of ± 5%. The plates were prewashed by methanol and activated at 60 ± 5°C for 2, 5 and 7 min prior to chromatography. Duration of saturation time of chamber was varied as 10, 15 and 20 min. Time from spotting to chromatography and time from chromatography to scanning was varied from 0, 20, 40 and 60 min. Robustness of the method was done at three different concentration levels.
Ruggedness: Ruggedness of the method was performed by spotting 400 ng of BF and 500 ng of HCTZ, respectively by two different analyst keeping same experimental and environmental conditions.
Limit of detection (LOD) and limit of quantitation (LOQ):
In order to determine detection and quantitation limit, concentrations in the lower part of the linear range of the calibration curve were used. Stock solutions of BF and HCTZ (1000 µg/ml) were prepared separately and different concentrations 200, 250, 300, 350 and 400 ng of BF and 100, 150, 200, 250 and 300 of HCTZ were separately spotted on TLC plates in triplicate. The LOQ and LOD were calculated using equation LOD=3.3×N/B and LOQ=10×N/B, where, N is standard deviation of the peak areas of the drugs (n=3), taken as a measure of noise, and B is the slope of the corresponding calibration curve.
Application of proposed method to tablet formulation
Twenty tablets were weighed; average weight determined and crushed in to fine powder. An accurately weighed tablet powder equivalent to 5 mg of bisoprolol and 6.25 mg of HCTZ was transferred into 25 ml volumetric flask containing 15 ml methanol, sonicated for 10 min and volume was made up to mark with same solvent. The resulting solution was filtered using 0.41 µm filter (Millifilter, milford, MA). 
